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Kang Sup Yoon, MD, and Hee Joong Kim, MD
Investigation performed at the Department of Orthopaedic Surgery, Seoul National University College of Medicine, Seoul, South Korea
Background: Magnetic resonance imaging has made it possible to detect asymptomatic lesions of osteonecrosis of
the femoral head before abnormalities appear on plain radiographs. The extent of a necrotic lesion is known to be an
important prognostic factor. In this study, we evaluated the fate of untreated asymptomatic osteonecrosis of the femoral
head with an emphasis on the size of the lesion. We hypothesized that a lesion smaller than a certain size would not
progress to symptomatic disease.
Methods: One hundred and five initially asymptomatic hips of patients with bilateral nontraumatic osteonecrosis of
the femoral head who had been followed without any treatment for at least five years or until pain developed were enrolled
in this study. The extent of a lesion was estimated according to the area of the lesion based on a two-dimensional analysis
on magnetic resonance images or on plain radiographs at the time of diagnosis.
Results: Sixty-two hips became symptomatic, and forty-three hips remained asymptomatic for more than five years
(average, eight years and seven months). Of the twenty-one hips with a small necrotic lesion (<30% of the area of the
femoral head), one became painful; of the twenty-four hips with a medium-sized necrotic lesion (30% to 50% of the area
of the femoral head), eleven became painful; and of the sixty hips with a large necrotic lesion (>50% of the area of the
femoral head), fifty became painful. Forty-six of the sixty-two hips that became symptomatic required surgery. Pain
developed within five years after the diagnosis in fifty-eight (94%) of the sixty-two symptomatic hips.
Conclusions: No treatment appears to be necessary for asymptomatic necrotic lesions with an area smaller than 30%
of the femoral head, as the vast majority of these lesions will remain asymptomatic for more than five years.
Level of Evidence: Prognostic Level II. See Instructions to Authors for a complete description of levels of evidence.
M
ost of the literature regarding the natural history
of nontraumatic osteonecrosis of the femoral head
has concerned symptomatic osteonecrosis1-6. Symp-
tomatic osteonecrosis of the femoral head that is not treated
generally progresses to collapse, and eventually painful oste-
oarthritis develops7-11. However, the fate of untreated asymp-
tomatic osteonecrosis of the femoral head remains unclear.
With the advent of magnetic resonance imaging, it
is possible to make an early diagnosis of osteonecrosis be-
fore radiographic evidence appears. In particular, magnetic
resonance imaging has made it easier to detect asympto-
matic lesions in patients with osteonecrosis of the femoral
head because most asymptomatic disease is not apparent
radiographically11.
Many variables, such as disease stage, lesion size or loca-
tion, the presence of pain, and radiographic evidence of collapse,
have been evaluated as factors in the prognosis of osteonecrosis
of the femoral head, and, of these, the extent of the necrotic
lesion has been considered the most important11-18.
In the present study, we investigated the fate of untreated
asymptomatic osteonecrosis of the femoral head on the basis of
the hypothesis that asymptomatic lesions that were smaller
than a certain size would not progress to symptomatic disease
without treatment.
Disclosure: The authors did not receive any outside funding or grants in support of their research for or preparation of this work. Neither they nor a
member of their immediate families received payments or other benefits or a commitment or agreement to provide such benefits from a commercial
entity. No commercial entity paid or directed, or agreed to pay or direct, any benefits to any research fund, foundation, division, center, clinical practice,
or other charitable or nonprofit organization with which the authors, or a member of their immediate families, are affiliated or associated.
A commentary is available with the electronic versions of this article, on our web site (www.jbjs.org) and on our quarterly CD-ROM (call our
subscription department, at 781-449-9780, to order the CD-ROM).
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Materials and Methods
From January 1982 to March 2005, 312 patients with bi-lateral nontraumatic osteonecrosis of the femoral head
presented to our department with pain in only one hip. The
diagnosis of nontraumatic osteonecrosis of the femoral head
was made on the basis of typical findings on plain radiographs
and/or magnetic resonance images. Patients in whom osteo-
necrosis had developed after a femoral neck fracture or a hip
dislocation were excluded. Of the 312 patients with an asymp-
tomatic hip, 128 were treated with a joint-preserving procedure
such as core decompression with or without bone-grafting,
multiple drilling, or transtrochanteric rotational osteotomy.
The remaining 184 were followed without any treatment for
the asymptomatic hip. Included in this group were patients in
whom no joint-preserving operation was recommended be-
cause they were older than fifty-five years of age as well as
patients who were younger than fifty-five years of age and were
advised to have a joint-preserving operation but refused it.
Seventy-nine hips that remained asymptomatic but were fol-
lowed for less than five years were excluded, leaving 105 hips
to be included in the final analysis. All of those hips were
followed for at least five years or until pain developed. In-
formed consent was obtained from all patients for participation
in the study, which was approved by the institutional review
board at our institute.
There were eighty-four men and twenty-one women
with a mean age of fifty years (range, twenty-three to seventy-
three years) at the time of the diagnosis. According to the
grading system described by Steinberg et al.15, sixty-two hips
(59%) were in stage I (normal findings on radiographs but
abnormal findings on magnetic resonance images) and forty-
three hips were in stage II (radiographs showing scleroses or
cysts but no crescent sign) at the time of diagnosis. The mean
duration of follow-up was seven years and eight months (range,
ten months to twenty-two years and eight months). The risk
factors associated with osteonecrosis were alcohol abuse (fifty-
four hips) and corticosteroid intake (twenty hips). Thirty-one
hips were considered to have idiopathic osteonecrosis.
The extent of the necrotic lesions was measured on
magnetic resonance images when available (seventy-eight
hips) or on plain radiographs (twenty-seven hips) at the time
of the diagnosis. Details of the method of measurement and its
accuracy and repeatability have been previously described19. In
brief, we measured the largest mediolateral diameter of the
femoral head (R) and the longest mediolateral length of the
necrotic lesion (A) on coronal magnetic resonance images or
on anteroposterior plain radiographs, and the largest antero-
posterior diameter of the femoral head (R9) and the longest
anteroposterior length of the necrotic lesion (B) on sagittal
magnetic resonance images or on frog-leg lateral plain radio-
graphs. The two-dimensional extent of a necrotic lesion was
determined with the equation: % area = (A · B/R · R9) · 100
(Figs. 1-A and 1-B).
The location of a necrotic lesion was classified as Type A
(less than the medial one-third of the weight-bearing area,
medial location), B (between the medial one-third and two-
thirds of the weight-bearing area, central location), and C
(greater than the medial two-thirds of the weight-bearing area,
lateral location) with use of the grading system described by
Nishii et al.5 on the midcoronal T1-weighted magnetic reso-
nance images (in seventy-eight hips) or on the anteroposterior
radiographs (in twenty-seven hips). Twenty-two hips were
classified as Type A; twenty-eight, as Type B; and fifty-five, as
Type C.
Demographic and clinical differences between hips that
remained painless and those that became painful were assessed.
Statistical Analysis
Nominal data were analyzed with use of the chi-square test and
continuous data, with the Student t test.
Three subgroups were defined according to the size of
the necrotic lesion: hips with necrosis of <30% of the area of
the femoral head, those with necrosis between 30% and 50%
of the area, and hips with necrosis of >50% of the area. Sur-
vival curves for these three groups were calculated with use of
the Kaplan-Meier method, with the development of pain as the
end point, and the time until pain developed was compared
among the three groups with use of the log-rank test. The same
analyses were done for the three types of lesion location.
We performed two different regression analyses. Linear
regression analysis (a method used to analyze the relationship
between two variables, X and Y) was conducted to determine
the relationship between the extent of the necrosis and the
time until pain developed in the hips that became painful.
Multivariate analyses were performed with use of the Cox
proportional-hazards model (a method used to investigate the
effects of the predictor variables on the time that an event takes
to happen) to identify independent factors with regard to
disease progression, defined as the development of pain. These
analyses were adjusted for age, gender, body mass index, as-
sociation with alcohol abuse and corticosteroid intake, and
initial stage. The level of significance was set at p < 0.05.
Results
The mean extent of the 105 necrotic lesions was 52.9%(range, 2% to 100%) of the area of the femoral head.
Sixty-two hips (59%) became painful and collapsed during the
follow-up period, and forty-three hips (41%) remained asymp-
tomatic and without collapse for more than five years (mean,
eight years and seven months; range, five to fifteen years).
Of the forty-three hips that remained asymptomatic,
thirteen that had been in stage I progressed to stage II; how-
ever, eleven hips in stage I and nineteen hips in stage II re-
mained in the same stage without evidence of femoral head
collapse at the time of the latest follow-up. All of the sixty-two
hips that became painful had progressed to femoral head
collapse: eight hips progressed from stage I to III; twenty-six,
from stage I to IV; three, from stage I to V; one, from stage I to
VI; three, from stage II to III; seventeen, from stage II to IV;
two from stage II to V; and two, from stage II to VI. The
development of pain had a significant correlation with the
occurrence of femoral head collapse (p < 0.0001).
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The mean interval between the initial diagnosis and the
development of pain was two years and one month (range, one
month to eleven years). In the majority (fifty-eight) of sixty-two
symptomatic hips, pain developed within five years. The pain
developed within one year in twenty-five hips (40%), within
two years in forty-one (66%), within three years in forty-seven
(76%), within four years in fifty-two (84%), within five years in
fifty-eight (94%), and within ten years in sixty-one (98%). (The
numbers of hips are cumulative.) A smaller extent of necrosis
was found to be significantly associated with a longer time
between the diagnosis and the development of pain (p = 0.008,
time to pain [in months] = 58.3 – 0.499 · % area of necrosis).
With the numbers studied, age, gender, and body mass
index were not found to be significantly associated with the
Fig. 1-B
Measurements on anteroposterior and frog-leg lateral radiographs.
Fig. 1-A
Figs. 1-A and 1-B Details of the method for measuring the percent area (extent) of a necrotic lesion. The extent of a necrotic portion
was determined with use of the equation: % extent = (A · B/R · R9) · 100, where R = the largest mediolateral diameter of
the femoral head, R9 = the largest anteroposterior diameter of the femoral head, A = the longest mediolateral length of the necrotic
lesion, and B = the longest anteroposterior length of the necrotic lesion. Fig. 1-A Measurements on coronal and sagittal
magnetic resonance images.
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development of pain (p > 0.30 for all, Table I). Cases related to
alcohol abuse became symptomatic more often than did those
related to corticosteroid intake or idiopathic causes. However,
multivariate analysis showed no significant relationship, with
the numbers available, between these risk factors and the de-
velopment of pain after adjustment for other variables, in-
cluding age, gender, body mass index, initial stage, lesion
extent, and lesion location (p = 0.43). No significant difference
was found between stage-I hips and stage-II hips with regard to
the development of pain (p = 0.58).
The extent of the necrotic lesion was found to be sig-
nificantly greater in the hips that became symptomatic (p <
0.0001), and adjusted multivariate analyses showed it to be a
significant independent predictor of disease progression (de-
fined as the development of pain) (p < 0.0001, Table II). An
increase in the extent of osteonecrosis by 1% was found to be
associated with a 1.029-fold increase in the risk of pain de-
veloping (95% confidence interval, 1.014 to 1.045).
The lesion location was found to be significantly asso-
ciated with the development of pain (p = 0.001), but it was not
found to be a significant independent predictor of disease
progression in the adjusted multivariate analysis (p = 0.3).
Pain developed in six of the twenty-two Type-A hips, fifteen of
the twenty-eight Type-B hips, and forty-one of the fifty-five
Type-C hips. With the development of pain as the end point, a
comparison of survival curves showed no significant differ-
ences among the three types (p = 0.23).
Of the sixty-two hips in which pain developed, forty-six
(74%) deteriorated sufficiently to require surgery and forty-
four of these were treated operatively; bipolar arthroplasty was
performed in three hips and total hip arthroplasty, in forty-one
hips. The remaining two patients were awaiting surgery at the
time of their latest follow-up. The average time between the
onset of pain and surgery was one year and seven months
(range, one month to ten years and ten months). Sixteen of the
sixty-two hips in which pain developed remained untreated at
TABLE II Adjusted Hazard Ratios for the Relationship Between
the Extent or Location of the Necrotic Lesion





Size (1% increment in
lesion size†)
1.029 (1.014-1.045) <0.0001
Large (>50% involvement) 13.540 (1.849-99.164) 0.010
Type C (lateral location) 1.604 (0.657-3.915) 0.300
*Analysis adjusted for age, gender, body mass index, association
with alcohol abuse and corticosteroid intake, and initial stage.
†The hazard to pain development increases 2.9% for each 1%
increment in size.
TABLE I Comparison of Data Between Hips That Remained Painless for More Than Five Years and Hips That Became Symptomatic
Variables No Pain (N = 43) Pain (N = 62)
Age*† (yr) 48.1 ± 12.4 50.6 ± 13.9
Male:female† (no.) 34:9 50:12
Body mass index*† (kg/m2) 23.1 ± 2.4 22.7 ± 2.7
Risk factors (no.)
Alcohol abuse‡ 15 39
Corticosteroid intake 10 10
Idiopathic 18 13
Follow-up period* (yr) 8.6 ± 3.0 7.1 ± 4.7
Initial stage (Stage I:II)†§ (no.) 24:19 38:24
Final stage (Stage I:II:III:IV:V:VI)§ (no.) 11:32:0:0:0:0 0:0:11:43:5:3
Extent of osteonecrosis*# (%) 33.4 ± 22.3 66.4 ± 16.9
Classification according to the extent (small:medium:large)** (no.) 20:13:10 1:11:50
Classification according to the location (Type A:B:C)†† (no.) 16:13:14 6:15:41
Surgical treatments (no.) 0 46
*Values represent the mean and standard deviation. †P > 0.30 for the difference between hips with pain and those without pain (Student t test or
chi-square test). ‡P = 0.016 for the difference between hips with pain and those without pain according to the chi-square test, but p = 0.43
according to the adjusted multivariate analysis (Cox proportional hazard model). §According to the grading system described by Steinberg et al.15.
#P < 0.0001 for the difference between hips with pain and those without pain (Student t test). **Small = <30% involvement, medium = 30% to
50% involvement, and large = >50% involvement. P < 0.0001 for the difference between hips with pain and those without pain (chi-square test).
††Type A = medial location, Type B = central location, and Type C = lateral location. P = 0.001 for the difference between hips with pain and those
without pain (chi-square test).
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Fig. 2-A
Figs. 2-A, 2-B, and 2-C Kaplan-Meier survivorship curves, with 95% confidence intervals, for the hips with different sizes of necrotic
lesion, with the development of pain as the end point. Asymptomatic hips were classified into three groups according to the extent of the
necrotic lesion. Differences between all groups were significant (log-rank test, p = 0.0006). Fig. 2-A Hips with a small lesion (involvement
of <30% of the area of the femoral head).
Fig. 2-B
Hips with a medium-sized lesion (involvement of 30% to 50% of the area of the femoral head).
Fig. 2-C
Hips with a large lesion (involvement of >50% of the area of the femoral head).
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Fig. 3-A
Figs. 3-A, 3-B, and 3-C A patient with osteonecrosis that remained painless despite substantial femoral head involvement. Fig. 3-A Anter-
oposterior radiograph showing a right asymptomatic hip in stage I (asterisk) and a left symptomatic hip in stage IV at the time of diagnosis.
Fig. 3-B
A coronal T1-weighted magnetic resonance image of the right hip (left image) shows a central necrotic lesion with normal bone between
the lesion and the articular cartilage of the weight-bearing portion (arrowheads), and a sagittal T1-weighted magnetic resonance image
(right image) also shows the lesion, with sparing of subchondral bone (arrowheads). This lesion was estimated to involve up to 76% of
the femoral head.
Fig. 3-C
The right hip was still asymptomatic without collapse at the time of final follow-up, at eleven years and four months. The left hip was
replaced four weeks after the diagnosis.
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the time of final follow-up, as the pain was not severe enough
to warrant surgery. A significant difference in the mean lesion
size was noted between the sixteen untreated hips (53.3% of
the area of the femoral head) and the forty-six hips that re-
quired surgery (70.9% of the area) (p < 0.0001).
Of the twenty-one hips with a small lesion (<30% of the
area of the femoral head), one became symptomatic; of the
twenty-four hips with a medium-sized lesion (30% to 50% of
the area), eleven became symptomatic; and of the sixty hips
with a large lesion (>50% of the area), fifty became sympto-
matic. With the development of pain as the end point, a
comparison of survival curves showed that hips with a small
lesion had a significantly longer survival duration than those
with a medium-sized or large lesion (p = 0.0096 and 0.0002,
respectively) (Figs. 2-A, 2-B, and 2-C). The one hip with a
small lesion that became painful had a far-lateral lesion, and
the ten large lesion hips that remained painless had a central
lesion with normal bone between the necrotic lesion and the
articular cartilage (that is, the subchondral bone was spared)
(Figs. 3-A, 3-B, and 3-C).
Discussion
Previous studies of asymptomatic osteonecrosis of thefemoral head have demonstrated various rates of disease
progression5,20-28. Differing opinions regarding the fate of asymp-
tomatic disease have been attributed to several reasons, in-
cluding differences in study populations, diagnostic modalities,
follow-up periods, and the definition of disease progression5,27.
In the present study, 105 asymptomatic hips with early stages
of disease were not treated. Sixty-two hips were followed until
pain developed, and the other forty-three remained painless
without collapse for five years or more. Therefore, the overall
rate of progression of asymptomatic osteonecrosis in this study
was 59%. These results are comparable with the overall rate of
66% (317 of 480) in the previous reports5,20-28 describing pro-
gression of asymptomatic disease. In our study, pain developed
in most hips (83%; fifty of sixty) in which the lesion involved
>50% of the femoral head, usually within three years (76%;
forty-seven of sixty-two hips).
The cohort of this study did not comprise all patients
with asymptomatic osteonecrosis of the femoral head. Patients
younger than fifty-five years of age were included only when
they had refused joint-preserving treatment. To minimize the
effect of this selection, we recommended joint-preserving
treatment to all patients younger than fifty-five years of age,
regardless of the size of the necrotic lesion.
The extent of a necrotic lesion is an important deter-
minant of prognosis11-18. The present study showed that,
among the various factors evaluated, the extent of the necrotic
lesion was the most important for predicting the prognosis of
asymptomatic osteonecrosis of the femoral head. In this study,
the rate of disease progression, defined as the development of
pain, was 5% for small necrotic lesions (<30% of the area of the
femoral head), 46% for medium-sized necrotic lesions (30% to
50% of the area), and 83% for large necrotic lesions (>50% of
the area). While Hungerford and Jones11 and Steinberg et al.15
defined small lesions as <15% of volume and large lesions as
>30% of volume, we defined small lesions as <30% of area and
large lesions as >50% of area. We used percent of area because
the measuring method was simple.
The results of this study suggest that the development of
pain is related to the occurrence of femoral head collapse, a
finding consistent with those reported by Nishii et al.5. In
addition, we found that the extent of the lesion was related to
the time that it took for pain to develop and the need for
surgery. Pain developed more slowly and rarely progressed
enough to require surgery in hips with smaller lesions.
We found that age, gender, body mass index, selected
risk factors associated with osteonecrosis, and initial radio-
graphic stage were not associated with the development of
pain. These results are similar to those of earlier studies re-
garding the natural course of early-stage disease, whether
asymptomatic or not5,12,18,24,25. In the present study, the extent of
the lesion appeared to be more important than the initial ra-
diographic stage as a factor in the fate of osteonecrosis of the
femoral head, particularly in its earlier stages, an observation
that is supported by the literature on the topic11,13,16,17,25.
Exceptional cases, in which a small lesion became painful
or a large lesion remained painless, suggest that the location of
the lesion is another important prognostic factor. In this study,
lesion location was closely related to the development of pain,
but it was not a significant prognostic factor for disease pro-
gression. This may be due to the fact that larger lesions usually
extended more laterally in the femoral head.
In the current study, one small necrotic lesion that be-
came painful was located far laterally in the femoral head.
Nishii et al.5,18 reported a poor prognosis for lesions in this
location despite a small size. Moreover, the ten large necrotic
lesions that remained painless in our study were located in the
central portion of the femoral head, and a substantial amount
of subchondral bone above these lesions had been spared. This
finding is consistent with reports by Ohzono et al.2 and Ito
et al.25, who also noted that centrally located lesions rarely
progressed to collapse despite a large size.
Many authors have reported that small necrotic lesions
remained asymptomatic for several years5,23-25,27. The results of
the present study strongly suggest that asymptomatic necrotic
lesions involving <30% of the femoral head typically have a
benign course for more than five years and do not need any
treatment unless they are located far laterally. When pain de-
veloped in our series, it almost always did so within five years
after the diagnosis. We are of the opinion that our duration of
follow-up of small lesions that remained painless was adequate
as it ranged from five to fifteen years and averaged seven years
and ten months. Hernigou et al., in two separate studies26,28,
reported that the majority of small asymptomatic osteone-
crotic lesions became symptomatic; 88% of forty hips became
symptomatic within a mean of six years and eight months after
the diagnosis and 91% of 121 hips did so within three years
after the diagnosis. The reason for this difference between their
results and ours is uncertain but may be related to different
study populations and different durations of follow-up. A
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larger proportion of the patients in one of their studies26
(eleven of forty compared with twenty of 105 in our study) had
steroid-related disease and were followed for a mean of eleven
years, and, in their other study28, all patients had sickle cell
disease and were followed for a mean of fourteen years.
We intend to continue observing the patients who were
enrolled in the present study closely. Nevertheless, we believe
that no treatment is necessary for asymptomatic necrotic le-
sions when they involve <30% of the area of the femoral head,
as calculated with our method. n
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